Skip to content
10-K

Annual Report

CervoMed Inc. CRVO

0001437749-26-008259

← back to feed
Filed
Mar 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 12, 2026 9.26M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$23.45M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$16.53M
Cash And Equivalents FY 2025 · Dec 31, 2025 $8.24M
Cash And Equivalents FY 2025 · Dec 31, 2024 $9M
Stockholders Equity FY 2025 · Dec 31, 2025 $18.22M
Stockholders Equity FY 2025 · Dec 31, 2024 $39.2M
Stockholders Equity FY 2025 · Dec 31, 2023 $7.38M
Current Liabilities FY 2025 · Dec 31, 2025 $4.66M
Current Liabilities FY 2025 · Dec 31, 2024 $3.88M
Total Liabilities FY 2025 · Dec 31, 2025 $4.66M
Total Liabilities FY 2025 · Dec 31, 2024 $3.88M
Current Assets FY 2025 · Dec 31, 2025 $22.88M
Current Assets FY 2025 · Dec 31, 2024 $43.08M
Total Assets FY 2025 · Dec 31, 2025 $22.88M
Total Assets FY 2025 · Dec 31, 2024 $43.08M
Eps Basic FY 2025 · Dec 31, 2025 −$2.98
Eps Basic FY 2025 · Dec 31, 2024 −$2.02
Sga Expense FY 2025 · Dec 31, 2025 $10.48M
Sga Expense FY 2025 · Dec 31, 2024 $9.17M
Rd Expense FY 2025 · Dec 31, 2025 $21.82M
Rd Expense FY 2025 · Dec 31, 2024 $18.8M
Net Income FY 2025 · Dec 31, 2025 −$26.97M
Net Income FY 2025 · Dec 31, 2024 −$16.29M
Operating Income FY 2025 · Dec 31, 2025 −$28.29M
Operating Income FY 2025 · Dec 31, 2024 −$18.23M
Revenue FY 2025 · Dec 31, 2025 $4.01M
Revenue FY 2025 · Dec 31, 2024 $9.74M